By Chelsea Naso ( November 23, 2015, 6:54 PM EST) -- U.S. pharmaceutical giant Pfizer is pushing forward with the largest tax inversion deal ever recorded, spotlighting the meager impact of recent efforts to close loopholes that allow companies to benefit from a lower foreign corporate tax rate as the company pursues a $160 billion merger with Irish drugmaker Allergan, experts say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.